Cyclobenzaprine
CAS 303-53-7 8 FDA-DMF suppliersSmall Molecule
Overview
Cyclobenzaprine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL669).
API suppliers (10)
Suppliers of Cyclobenzaprine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Dipharma Francis SrlItaly1 active DMF
- MEDICHEM SASpain1 active DMF
- MEDICHEM SASpain1 active DMF
- Dipharma Francis SrlItaly1 active DMF
- MEDICHEM SASpain1 active DMF
- VASUDHA PHARMA CHEM LTD1 active DMF
- VASUDHA PHARMA CHEM LTD1 active DMF
- FERMION OYFinland
- CILAG AGSwitzerland
- FLEMING LABORATORIES LTDIndia
Patent & exclusivity (US)
Per the FDA Orange Book (40 approved US products), the latest listed US patent on Cyclobenzaprine expires 14 Mar 2034 and exclusivity 14 Aug 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine
- Canonical SMILES
- CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
- InChIKey
- JURKNVYFZMSNLP-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.